glp-1 medications nutrient deficiency effects and Vitamin D Deficiency: What to Know GLP-1 Medications: Understanding Vitamin Deficiency
Description
In June 2021, the FDA approved Wegovy as a weight loss medication for adults battling obesity and those overweight due to specific health issues

Eli Lilly is also assessing the safety and efficacy of retatrutide for chronic weight management and in patients with knee osteoarthritis and obstructive sleep apnea, as part of its TRIUMPH Phase III development program

It helps patients stay on therapy long enough to realize the benefits these medications are designed to provide
Monitoring during this phase ensures that the body continues to respond well to the medication

PlexusDx Precision Peptide Genetic Test examines variants in the GLP1R gene (rs6923761) and other key loci that predict how your body responds to semaglutideincluding indirect effects on circadian sensitivity and melatonin receptor expression

10.3389/fendo.2018.00584 [DOI] [PMC free article] [PubMed] [Google Scholar] RamosLobo, A